Beta-N-oxalyl-L-
alpha-beta-diaminopropionic acid (beta-L-
ODAP) is an unusual
amino acid present in seeds of plants from the Lathyrus genus that is generally accepted as the causative agent underlying the motor neuron degeneration and
spastic paraparesis in human
neurolathyrism. Much of the neuropathology produced by beta-L-
ODAP appears to be a direct consequence of its structural similarities to the excitatory
neurotransmitter L-glutamate and its ability to induce excitotoxicity as an agonist of non-
NMDA receptors. Its actions within the CNS are, however, not limited to non-
NMDA receptors, raising the likely possibility that the anatomical and cellular specificity of the neuronal damage observed in
neurolathyrism may result from the cumulative activity of beta-L-
ODAP at multiple sites. Accumulating evidence suggests that system xc-, a transporter that mediates the exchange of
L-cystine and
L-glutamate, is one such site. In the present work, two distinct approaches were used to define the interactions of beta-L-
ODAP with system xc-: Traditional radiolabel-uptake assays were employed to quantify inhibitory activity, while fluorometrically coupled assays that follow the exchange-induced efflux of
L-glutamate were used to assess substrate activity. In addition to confirming that beta-L-
ODAP is an effective competitive inhibitor of system xc-, we report that the compound exhibits a substrate activity comparable to that of the endogenous substrate
L-cystine. The ability of system xc- to transport and accumulate beta-L-
ODAP identifies additional variables that could influence its toxicity within the CNS, including the ability to limit its access to EAA receptors by clearing the
excitotoxin from the extracellular synaptic environment, as well as serving as a point of entry through which beta-L-
ODAP could have increased access to intracellular targets.